All Stories

  1. Intracellular Trafficking and Persistence of Acinetobacter baumannii Requires Transcription Factor EB

    Article • mSphere, March 2018, ASM Journals

    Dr. Jerónimo Pachón, Younes Smani

  2. Heteroresistance to Piperacillin-Tazobactam in Clinical Isolates of Escherichia coli Sequence Type 131

    Article • Antimicrobial Agents and Chemotherapy, October 2017, ASM Journals

    Younes Smani

  3. New molecules and adjuvants in the treatment of infections byAcinetobacter baumannii

    Article • Expert Opinion on Pharmacotherapy, April 2016, Taylor & Francis

    Younes Smani

  4. Use of adjuvants in the treatment ofAcinetobacter baumannii

    Article • Expert Review of Anti-infective Therapy, December 2015, Taylor & Francis

    Dr. Jerónimo Pachón, Younes Smani

  5. Therapeutic Efficacy of Lysophosphatidylcholine in Severe Infections Caused by Acinetobacter baumannii

    Article • Antimicrobial Agents and Chemotherapy, April 2015, ASM Journals

    Younes Smani

  6. Role of OmpA in the Multidrug Resistance Phenotype of Acinetobacter baumannii

    Article • Antimicrobial Agents and Chemotherapy, December 2013, ASM Journals

    Younes Smani

  7. HBOC Interferences with Routine Clinical Laboratory Tests

    Article • January 2013, Springer Science + Business Media

    Younes Smani

  8. Loss of the OprD Homologue Protein in Acinetobacter baumannii: Impact on Carbapenem Susceptibility

    Article • Antimicrobial Agents and Chemotherapy, December 2012, ASM Journals

    Younes Smani

  9. Role of Fibronectin in the Adhesion of Acinetobacter baumannii to Host Cells

    Article • PLoS ONE, April 2012, PLOS

    Younes Smani

  10. Acinetobacter baumannii-induced lung cell death: Role of inflammation, oxidative stress and cytosolic calcium

    Article • Microbial Pathogenesis, May 2011, Elsevier

    Younes Smani